← Leaderboards
Harold C Smith
University Of Rochester
$6,437,357
Attributed
$6,437,357
Total exposure
8
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1M · FY2005–17$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$6,437,357 · 8
By mechanism
R01$4,269,380 · 3
R21$2,167,977 · 5
Top collaborators
No co-investigators on record.
Most similar at University Of Rochester
Same institution · by research overlap
- Robert A Burne$30,932,674
- Thomas Harrison Foster$6,987,839
- Rashid Deane$3,735,499
Others in their field
Top investigators on “Validation”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$515,091,456
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Gary D Acton · University Of California-Davis$320,373,312
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- David Heimbrook · Leidos Biomedical Research, Inc.$239,311,963
Research focus
ValidationCellsMutationHigh Throughput ScreeningAntiviral AgentsProteinsMolecular ProbesDoseCytotoxicityViralHost DefenseLifeResponsePublic Health RelevanceHiv InfectionsFutureBaseLeadScaffoldBinding (Molecular Function)PropertyInnovationPreventResistant Strain
Grant awards (21)
Discovery of Chemical Probes for RNA-Binding Protein Host Defense Factors$560,451
R01 · FY2017 · GM · contact PI
Binding Interface of HIV Vif and APOBEC3G as a Therapeutic Target$200,879
R21 · FY2017 · AI · contact PI
Discovery of Chemical Probes for RNA-Binding Protein Host Defense Factors$605,606
R01 · FY2016 · GM · contact PI
Binding Interface of HIV Vif and APOBEC3G as a Therapeutic Target$403,638
R21 · FY2016 · AI · contact PI
Discovery of Chemical Probes for RNA-Binding Protein Host Defense Factors$601,514
R01 · FY2015 · GM · contact PI
Identification of Antagonists of the Molecular Chaperone Function of CBF beta$439,233
R01 · FY2015 · GM · contact PI
Identification of Antagonists of the Molecular Chaperone Function of CBF beta$439,233
R01 · FY2014 · GM · contact PI
Identification of Antagonists of the Molecular Chaperone Function of CBF beta$44,845
R01 · FY2014 · GM · contact PI
Identification of Antagonists of the Molecular Chaperone Function of CBF beta$468,483
R01 · FY2013 · GM · contact PI
Development of a Novel HIV/AIDS Therapeutic Activating the APOBEC3G Host Defense$210,000
R21 · FY2012 · AI · contact PI
Development of a Novel HIV/AIDS Therapeutic Activating the APOBEC3G Host Defense$252,000
R21 · FY2011 · AI · contact PI
Development of a High Throughput Screen for Antagonists of Vif Dimerization$32,250
R21 · FY2011 · NS · contact PI
Development of a High Throughput Screen for Antagonists of Vif Dimerization$128,710
R21 · FY2009 · NS · contact PI
Based deamination by CEM15 suppresses HIV-1 Infectivity$234,000
R21 · FY2005 · AI
The Role of mRNA Editing in B Cell Development$236,250
R21 · FY2004 · AI
Based deamination by CEM15 suppresses HIV-1 Infectivity$234,000
R21 · FY2004 · AI
METABOLIC REGULATION OF APOLIPOPROTEIN B MRNA EDITING$279,125
R01 · FY2003 · DK
Role of mRNA Editing in B Cell Development$236,250
R21 · FY2003 · AI
METABOLIC REGULATION OF APOLIPOPROTEIN B MRNA EDITING$279,125
R01 · FY2002 · DK
METABOLIC REGULATION OF APOLIPOPROTEIN B MRNA EDITING$279,125
R01 · FY2001 · DK
METABOLIC REGULATION OF APOLIPOPROTEIN B MRNA EDITING$272,640
R01 · FY2000 · DK